R. Jude Samulski works in Heart Failure & Transplant affiliated with University of North Carolina at Chapel Hill.
R. Jude Samulski is a Professor of Pharmacology at the University of North Carolina at Chapel Hill and Director of the UNC Gene Therapy Center. He serves as the founder and Acting Chief Scientific Officer of Asklepios BioPharmaceuticals, Inc., a company developing gene therapies including for cardiovascular conditions. His research focuses on adeno-associated virus vectors for gene therapy, with applications in treating heart failure and other cardiovascular diseases.
441 pubs · 36,711 cites · h-index 98
PhD
University of Florida
1982
BS
Clemson University
1976
Professor, Department of Pharmacology
University of North Carolina at Chapel Hill · 1999 - Present
Director, Gene Therapy Center
University of North Carolina at Chapel Hill · 1993 - Present
Founder and Acting Chief Scientific Officer
Asklepios BioPharmaceuticals, Inc. · 2003 - Present
Associate Professor, Department of Pharmacology
University of North Carolina at Chapel Hill · 1993 - 1999
Assistant Professor, Department of Biological Sciences
University of Pittsburgh · 1986 - 1992